Ionis Pharmaceuticals, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$77.5M
28 notices · 998,803 sh
Mar 3 to Oct 4
Reported ·
$124.2M
120 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
93 of 120 reported sales carry the 10b5-1 box. Together they are 0.97% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-07-07Diaz Allene M., Director$863,637
2026-07-07Kordasiewicz Holly B., EVP, Chief Development Officer$108,494
2026-07-07BENNETT C FRANK, EVP, Chief Scientific Officer$5,724,724
2026-07-01KLEIN JOSEPH III, Director$910,417
2026-06-26Baroldi Mariana, Member of immediate family of any of the foregoing$451,699
2026-06-26O'NEIL PATRICK R., EVP CLO & General Counsel$245,520
Form 4, 2026-06-30: sold 3,069 at $80.00 Form 4 ↗
2026-06-26Schneider Eugene, EVP, Chf Clinical Develop Ofcr$3,880,807
Form 4, 2026-06-30: sold 26,000 at $81.05 Form 4 ↗
2026-06-25Swayze Eric, EVP Research$839,287
Form 4, 2026-06-26: sold 10,602 at $79.18 Form 4 ↗
2026-06-15BERTHELSEN SPENCER R, Director$587,920
Form 4, 2026-06-16: sold 8,000 at $73.49 Form 4 ↗
2026-06-12Kordasiewicz Holly B., EVP, Chief Development Officer$4,466,425
Form 4, 2026-06-16: sold 60,846 at $73.40 Form 4 ↗
2026-06-01BERTHELSEN SPENCER R, Director$605,360
Form 4, 2026-06-03: sold 8,000 at $75.67 Form 4 ↗
2026-05-13Monia Brett P, Chief Executive Officer$7,801,300
Form 4, 2026-05-15: sold 4,536 at $78.49 Form 4 ↗
2026-05-04LOSCALZO JOSEPH, Director$4,345,680
Form 4, 2026-05-06: sold 77,289 at $75.06 Form 4 ↗
2026-04-28Baroldi Joseph, EVP, Chief Business Officer$116,727
Form 4, 2026-04-30: sold 1,626 at $71.79 Form 4 ↗
2026-04-16Jenne Kyle, EVP, Chf GL Pdt Str Ofcr$369,600
Form 4, 2026-04-17: sold 4,902 at $75.17 Form 4 ↗
2026-04-16Birchler Brian, EVP, Corp and Development Ops$73,362
Form 4, 2026-04-17: sold 973 at $75.04 Form 4 ↗
2026-04-16Baroldi Joseph, EVP, Chief Business Officer$423,660
Form 4, 2026-04-17: sold 5,619 at $74.56 Form 4 ↗
2026-03-19Schneider Eugene, EVP, Chf Clinical Develop Ofcr$412,486
Form 4, 2026-03-23: sold 5,812 at $70.97 Form 4 ↗
2026-03-16HOUGEN ELIZABETH L, EVP, Finance & CFO$16.3M
Form 4, 2026-03-18: sold 225,220 at $72.43 Form 4 ↗
2026-03-10Jenne Kyle, EVP, Chf GL Pdt Str Ofcr$4,402,296
Form 4, 2026-03-11: sold 37,277 at $75.85 Form 4 ↗
2026-03-09O'NEIL PATRICK R., EVP CLO & General Counsel$994,612
Form 4, 2026-03-11: sold 10,148 at $75.25 Form 4 ↗
2026-03-03Diaz Allene M., Director$5,469,600
Form 4, 2026-03-05: sold 54,878 at $79.35 Form 4 ↗
2026-03-03BENNETT C FRANK, EVP, Chief Scientific Officer$7,056,227
Form 4, 2026-03-05: sold 85,089 at $79.23 Form 4 ↗
2026-03-03LOSCALZO JOSEPH, Director$1,920,000
Form 4, 2026-03-05: sold 1,032 at $80.27 Form 4 ↗
2026-03-03Baroldi Mariana, Officer$655,840
2026-03-03Baroldi Joseph, EVP, Chief Business Officer$325,059
Form 4, 2026-03-05: sold 6,659 at $79.74 Form 4 ↗
2026-03-03KLEIN JOSEPH III, Director$5,035,928
Form 4, 2026-03-05: sold 21,332 at $79.51 Form 4 ↗